Drug company Reckitt Benckiser has been marketing Nurofen under different sub-brands with the implication being that each one targeted different types of pain. Only one problem with that, and it led to action in Australia.
“The ACCC took these proceedings because it was concerned that consumers may have purchased these products in the belief that they specifically treated a certain type of pain, based on the representations on the packaging, when this was not the case,” Sims said. “Truth in advertising and consumer issues in the health and medical sectors are priority areas for the ACCC, to ensure that consumers are given accurate information when making their purchasing decisions.”
Quite how this strategy got approved is beyond me. I was staring at these packages a couple of months ago when I was suffering with a migraine and looked at the details on the back. I couldn’t figure out what the difference was, and this is why.
Advertising and branding come in for a lot of stick, and this is a good example of why. It’s shameful.